Cogstate Limited (CGS.AX)
AUD 1.36
(0.74%)
AUD 1.36
(0.74%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 66.27 Million AUD | 10.2% |
| 2023 | 60.13 Million USD | -3.04% |
| 2022 | 62.02 Million USD | 41.55% |
| 2021 | 43.81 Million AUD | 29.0% |
| 2020 | 33.96 Million AUD | 11.26% |
| 2019 | 30.53 Million AUD | -18.3% |
| 2018 | 37.37 Million AUD | 6.74% |
| 2017 | 35.01 Million AUD | 28.48% |
| 2016 | 27.25 Million AUD | 121.05% |
| 2015 | 12.32 Million AUD | 6.76% |
| 2014 | 11.54 Million AUD | 1.53% |
| 2013 | 11.37 Million AUD | -7.5% |
| 2012 | 12.29 Million AUD | 41.45% |
| 2011 | 8.69 Million AUD | 7.83% |
| 2010 | 8.06 Million AUD | 19.05% |
| 2009 | 6.77 Million AUD | 87.05% |
| 2008 | 3.61 Million AUD | 81.62% |
| 2007 | 1.99 Million AUD | 29.38% |
| 2006 | 1.54 Million AUD | 96.95% |
| 2005 | 782.14 Thousand AUD | 482.38% |
| 2004 | 134.3 Thousand AUD | -34.08% |
| 2003 | 203.74 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 34.86 Million AUD | 0.0% |
| 2024 FY | 66.27 Million AUD | 10.2% |
| 2024 Q2 | 27.67 Million AUD | 0.0% |
| 2023 Q2 | 26.02 Million AUD | 0.0% |
| 2023 FY | 60.13 Million USD | -3.04% |
| 2023 Q4 | 34.07 Million AUD | 0.0% |
| 2022 Q4 | 33.41 Million AUD | 0.0% |
| 2022 Q2 | 28.65 Million AUD | 0.0% |
| 2022 FY | 62.02 Million USD | 41.55% |
| 2021 Q4 | 25.47 Million AUD | 0.0% |
| 2021 Q2 | 18.02 Million AUD | 0.0% |
| 2021 FY | 43.81 Million AUD | 29.0% |
| 2020 Q2 | 12.69 Million AUD | 0.0% |
| 2020 Q4 | 22.84 Million AUD | 0.0% |
| 2020 FY | 33.96 Million AUD | 11.26% |
| 2019 FY | 30.53 Million AUD | -18.3% |
| 2019 Q4 | 15.19 Million AUD | 0.0% |
| 2018 FY | 37.37 Million AUD | 6.74% |
| 2017 FY | 35.01 Million AUD | 28.48% |
| 2016 FY | 27.25 Million AUD | 121.05% |
| 2015 FY | 12.32 Million AUD | 6.76% |
| 2014 FY | 11.54 Million AUD | 1.53% |
| 2013 Q3 | 3.11 Million AUD | 0.0% |
| 2013 FY | 11.37 Million AUD | -7.5% |
| 2013 Q1 | 3 Million AUD | 0.0% |
| 2013 Q2 | 3.11 Million AUD | 3.73% |
| 2013 Q4 | 3.11 Million AUD | 0.0% |
| 2012 Q2 | 3 Million AUD | 47.72% |
| 2012 FY | 12.29 Million AUD | 41.45% |
| 2012 Q3 | 3 Million AUD | 0.0% |
| 2012 Q1 | 2.03 Million AUD | 0.0% |
| 2012 Q4 | 3 Million AUD | 0.0% |
| 2011 Q1 | 2.37 Million AUD | 0.0% |
| 2011 Q2 | 2.03 Million AUD | -14.25% |
| 2011 FY | 8.69 Million AUD | 7.83% |
| 2011 Q3 | 2.03 Million AUD | 0.0% |
| 2011 Q4 | 2.03 Million AUD | 0.0% |
| 2010 Q4 | 2.37 Million AUD | 0.0% |
| 2010 Q2 | 2.37 Million AUD | 13.09% |
| 2010 Q3 | 2.37 Million AUD | 0.0% |
| 2010 FY | 8.06 Million AUD | 19.05% |
| 2010 Q1 | 2.09 Million AUD | 0.0% |
| 2009 Q4 | 2.09 Million AUD | 0.0% |
| 2009 Q2 | 2.09 Million AUD | 121.68% |
| 2009 Q1 | 945.87 Thousand AUD | 0.0% |
| 2009 Q3 | 2.09 Million AUD | 0.0% |
| 2009 FY | 6.77 Million AUD | 87.05% |
| 2008 Q2 | 945.87 Thousand AUD | 51.35% |
| 2008 FY | 3.61 Million AUD | 81.62% |
| 2008 Q4 | 945.87 Thousand AUD | 0.0% |
| 2008 Q3 | 945.87 Thousand AUD | 0.0% |
| 2008 Q1 | 624.96 Thousand AUD | 0.0% |
| 2007 FY | 1.99 Million AUD | 29.38% |
| 2007 Q2 | 624.96 Thousand AUD | 20.42% |
| 2007 Q4 | 624.96 Thousand AUD | 0.0% |
| 2007 Q3 | 624.96 Thousand AUD | 0.0% |
| 2007 Q1 | 518.98 Thousand AUD | 0.0% |
| 2006 Q2 | 518.98 Thousand AUD | 102.38% |
| 2006 FY | 1.54 Million AUD | 96.95% |
| 2006 Q4 | 518.98 Thousand AUD | 0.0% |
| 2006 Q3 | 518.98 Thousand AUD | 0.0% |
| 2006 Q1 | 256.44 Thousand AUD | 0.0% |
| 2005 Q4 | 256.44 Thousand AUD | 0.0% |
| 2005 Q2 | 256.44 Thousand AUD | 434.0% |
| 2005 FY | 782.14 Thousand AUD | 482.38% |
| 2005 Q1 | 48.02 Thousand AUD | 0.0% |
| 2005 Q3 | 256.44 Thousand AUD | 0.0% |
| 2004 Q2 | 48.02 Thousand AUD | -36.47% |
| 2004 Q1 | 75.59 Thousand AUD | 0.0% |
| 2004 Q3 | 48.02 Thousand AUD | 0.0% |
| 2004 Q4 | 48.02 Thousand AUD | 0.0% |
| 2004 FY | 134.3 Thousand AUD | -34.08% |
| 2003 Q4 | 75.59 Thousand AUD | 0.0% |
| 2003 Q3 | 75.59 Thousand AUD | 0.0% |
| 2003 Q2 | 75.59 Thousand AUD | 0.0% |
| 2003 FY | 203.74 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alcidion Group Limited | 37.05 Million AUD | -78.84% |
| Artrya Limited | - AUD | -Infinity% |
| Beamtree Holdings Limited | 27.6 Million AUD | -140.11% |
| Careteq Limited | 7.23 Million AUD | -816.458% |
| Doctor Care Anywhere Group PLC | 72.02 Million AUD | 7.991% |
| Emyria Limited | 2.2 Million AUD | -2908.685% |
| Global Health Limited | 8.12 Million AUD | -715.894% |
| HITIQ Limited | 4.74 Million AUD | -1295.546% |
| Intelicare Holdings Limited | 280.29 Thousand AUD | -23544.204% |
| ImExHS Limited | 19.66 Million AUD | -236.94% |
| Mach7 Technologies Limited | 29.12 Million AUD | -127.538% |
| MedAdvisor Limited | 122.1 Million AUD | 45.725% |
| Oakridge International Limited | 814.73 Thousand AUD | -8034.308% |
| Opyl Limited | 397.63 Thousand AUD | -16566.662% |
| PainChek Limited | 2.67 Million AUD | -2380.328% |
| Pro Medicus Limited | 161.5 Million AUD | 58.964% |
| Resonance Health Limited | 8.58 Million AUD | -671.557% |
| Singular Health Group Ltd | 90.82 Thousand AUD | -72867.589% |
| Total Brain Limited | 8.41 Million AUD | -687.5% |